Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2018
TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 ActivationRachel A Woolaver, Xiaoguang Wang, Yonatan Dollin, et al.
Molecular Carcinogenesis|February 5, 2020
Tumor immune microenvironment in head and neck cancersSamantha M Y Chen, Alexandra L Krinsky, Rachel A Woolaver, et al.
Protein & Cell|March 13, 2020
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphomaXiaoguang Wang, Brittany C Waschke, Rachel A Woolaver, et al.
Cellular & Molecular Immunology|May 20, 2020
MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cellsXiaoguang Wang, Brittany C Waschke, Rachel A Woolaver, et al.
Plos One|July 4, 2014
Fibroblast growth factor 8 deficiency compromises the functional response of the serotonergic system to stressLeah R Brooks, Heide L Pals, Courtney L Enix, et al.
Cancer Immunology Research|June 26, 2019
Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell LymphomasXiaoguang Wang, Brittany C Waschke, Rachel A Woolaver, et al.
Frontiers in Immunology|April 13, 2023
Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-respondersJessy John, Samantha M Y Chen, Rachel A Woolaver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and AnergyZhangguo Chen, Alexandra Krinsky, Rachel A Woolaver, et al.
Frontiers in Immunology|November 4, 2022
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumorsJessy John, Rachel A Woolaver, Vince Popolizio, et al.
Communications Biology|August 26, 2021
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinomaAlexander A Strait, Rachel A Woolaver, Spencer C Hall, et al.
Pageof 2